Related Experiment Video
Updated: Sep 20, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
CZecking heart failure in patients with advanced chronic kidney disease (Czech HF-CKD): Study protocol
Jan Malik1, Anna Valerianova1, Satu Sinikka Pesickova2,3
1Third Department of Internal Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Insights
New heart failure (HF) definitions for hemodialysis patients may improve identification of those at high risk for cardiovascular events. These novel criteria aim to better distinguish HF from fluid overload in this vulnerable population.
Area of Science:
- Cardiology
- Nephrology
- Clinical Research
Background:
- Heart failure (HF) is a major cause of mortality in end-stage kidney disease (ESKD) patients undergoing hemodialysis.
- Distinguishing HF from fluid overload is challenging due to limitations of traditional HF definitions and exercise limitations unrelated to HF in this population.
Purpose of the Study:
- To evaluate two novel heart failure (HF) definitions in hemodialysis patients.
- To compare the efficacy of these new definitions against the traditional HF definition in identifying patients with adverse cardiovascular outcomes and advanced structural heart disease.
Main Methods:
- A longitudinal observational study involving 300 hemodialysis patients across six centers.
- Detailed hemodynamic assessments including echocardiography, cardiac output calculation, arteriovenous fistula flow, and bio-impedance.
- Primary composite endpoint includes cardiovascular death, HF worsening/new diagnosis, and non-fatal myocardial infarction or stroke.
Main Results:
- The study aims to compare the time to major endpoint events between the traditional HF definition and the two proposed novel definitions.
- Analysis will focus on identifying which definition best correlates with adverse cardiovascular outcomes and structural heart disease progression.
Conclusions:
- Novel hemodynamic and modified HF definitions show promise for improved accuracy in identifying high-risk hemodialysis patients.
- Accurate HF assessment in ESKD patients is crucial for timely intervention and improved patient outcomes.
Background:
Heart failure (HF) is a frequent cause of morbidity and mortality of end-stage kidney disease (ESKD) patients on hemodialysis. It is not easy to distinguish HF from water overload. The traditional HF definition has low sensitivity and specificity in this population. Moreover, many patients on hemodialysis have exercise limitations unrelated to HF. Therefore, we postulated two new HF definitions ((1) Modified definition of the Acute Dialysis Quality Improvement working group; (2) Hemodynamic definition based on the calculation of the effective cardiac output). We hypothesize that the newer definitions will better identify patients with higher number of endpoints and with more advanced structural heart disease.
Methods:
Cohort, observational, longitudinal study with recording predefined endpoints. Patients (n = 300) treated by hemodialysis in six collaborating centers will be examined centrally in a tertiary cardiovascular center every 6-12 months lifelong or till kidney transplantation by detailed expert echocardiography with the calculation of cardiac output, arteriovenous dialysis fistula flow volume calculation, bio-impedance, and basic laboratory analysis including NTproBNP. Effective cardiac output will be measured as the difference between measured total cardiac output and arteriovenous fistula flow volume and systemic vascular resistance will be also assessed non-invasively. In case of water overload during examination, dry weight adjustment will be recommended, and the patient invited for another examination within 6 weeks. A composite major endpoint will consist of (1) Cardiovascular death; (2) HF worsening/new diagnosis of; (3) Non-fatal myocardial infarction or stroke. The two newer HF definitions will be compared with the traditional one in terms of time to major endpoint analysis.
Discussion:
This trial will differ from others by: (1) detailed repeated hemodynamic assessment including arteriovenous access flow and (2) by careful assessment of adequate hydration to avoid confusion between HF and water overload.
More Related Videos
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Related Concept Videos
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Heart Failure Drugs: Diuretics
Chronic Kidney Disease I: Introduction